IL246002B2
Substituted heterocycle fused gamma-carboline compounds for use in the treatment of residual symptoms of psychosis and a long acting injectable composition comprising such compounds in a matrix
Abstract
This record has no abstract on file.
Term
No projected expiry on record.
- Priority and filed
- Published
- Today
Every citation, both ways
| Document | Relation | Office | Category | Cited during | Relevant claims |
|---|---|---|---|---|---|
| US2006178362A1 | Cites | United States of America | XY | Search report | 1-5 |
| WO2011133224A1 | Cites | World Intellectual Property Organization (WIPO) | XY | Search report | 26,29-30 |
85 members in 17 offices
Members85
| Document | Office | Kind | |
|---|---|---|---|
| CA2932610A1 | Canada | A1 | |
| CA3148303A1 | Canada | A1 | |
| CA3148326A1 | Canada | A1 | |
| CA3205777A1 | Canada | A1 | |
| WO2015085004A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU2014360452A1 | Australia | A1 | |
| IL246002A0 | Israel | A0 | |
| IL246002D0 | Israel | D0 | |
| KR20160093055A | Republic of Korea | A | |
| CN105939712A | China | A | |
| MX2016007219A | Mexico | A | |
| EP3076967A1 | European Patent Office (EPO) | A1 | |
| US2016310502A1 | United States of America | A1 | |
| JP2016539144A | Japan | A | |
| EP3076967A4 | European Patent Office (EPO) | A4 | |
| BR112016012781A2 | Brazil | A2 | |
| RU2016126445A | Russian Federation | A | |
| US9956227B2 | United States of America | B2 | |
| US2018200256A1 | United States of America | A1 | |
| AU2014360452B2 | Australia | B2 | |
| AU2019200301A1 | Australia | A1 | |
| JP6475727B2 | Japan | B2 | |
| RU2682658C1 | Russian Federation | C1 | |
| AU2014360452C1 | Australia | C1 | |
| JP2019077724A | Japan | A | |
| US10322134B2 | United States of America | B2 | |
| US2019290655A1 | United States of America | A1 | |
| US2019298730A1 | United States of America | A1 | |
| US2019328745A1 | United States of America | A1 | |
| AU2019200301B2 | Australia | B2 | |
| AU2020202386A1 | Australia | A1 | |
| EP3666271A1 | European Patent Office (EPO) | A1 | |
| US10960009B2 | United States of America | B2 | |
| US10960010B2 | United States of America | B2 | |
| KR20210049199A | Republic of Korea | A | |
| KR20210049200A | Republic of Korea | A | |
| JP6874028B2 | Japan | B2 | |
| JP2021075566A | Japan | A | |
| US11026951B2 | United States of America | B2 | |
| MX383855B | Mexico | B | |
| EP3076967B1 | European Patent Office (EPO) | B1 | |
| KR102287288B1 | Republic of Korea | B1 | |
| KR20210101326A | Republic of Korea | A | |
| AU2020202386B2 | Australia | B2 | |
| PT3076967T | Portugal | T | |
| US2021322433A1 | United States of America | A1 | |
| DK3076967T3 | Denmark | T3 | |
| PL3076967T3 | Poland | T3 | |
| AU2021290277A1 | Australia | A1 | |
| ES2893621T3 | Spain | T3 | |
| HUE056496T2 | Hungary | T2 | |
| KR102372145B1 | Republic of Korea | B1 | |
| KR102373288B1 | Republic of Korea | B1 | |
| AU2020202386C1 | Australia | C1 | |
| CN114366741A | China | A | |
| IL246002B | Israel | B | |
| KR102421656B1 | Republic of Korea | B1 | |
| KR20220103822A | Republic of Korea | A | |
| IL293523A | Israel | A | |
| MX2021007665A | Mexico | A | |
| MX395458B | Mexico | B | |
| MX2022011140A | Mexico | A | |
| KR102495941B1 | Republic of Korea | B1 | |
| KR20230023817A | Republic of Korea | A | |
| JP7262495B2 | Japan | B2 | |
| KR20230058736A | Republic of Korea | A | |
| JP2023089113A | Japan | A | |
| AU2021290277B2 | Australia | B2 | |
| CA2932610C | Canada | C | |
| IL293523B1 | Israel | B1 | |
| IL305990A | Israel | A | |
| US2024024334A1 | United States of America | A1 | |
| IL293523B2 | Israel | B2 | |
| CA3148303C | Canada | C | |
| KR102692169B1 | Republic of Korea | B1 | |
| KR20240119197A | Republic of Korea | A | |
| IL246002B2This record | Israel | B2 | |
| JP7600299B2 | Japan | B2 | |
| JP2025032193A | Japan | A | |
| MX383855B | Mexico | B | |
| MX395458B | Mexico | B | |
| IL305990B1 | Israel | B1 | |
| IL321987A | Israel | A | |
| US2025360140A1 | United States of America | A1 | |
| IL305990B2 | Israel | B2 |
Numbers
- Publication
- 246002
- Application
- 246002
Titles2
- English
- SUBSTITUTED HETEROCYCLE FUSED GAMMA-CARBOLINE COMPOUNDS FOR USE IN THE TREATMENT OF RESIDUAL SYMPTOMS OF PSYCHOSIS AND A LONG ACTING INJECTABLE COMPOSITION COMPRISING SUCH COMPOUNDS IN A MATRIX
- Hebrew
- תרכובות מותמרות של גאמא–קרבולין מאוחה עם הטרוציקלים לשימוש בטיפול בתסמינים שאריתיים של פסיכוזה ותכשיר להזרקה בעל פעילות ארוכת טווח המכיל תרכובות אלו במטריצה
Classification
- CPC, 17
- A61K31/437
- A61K31/5383
- A61K9/0019
- A61K31/4985
- A61K2300/00
- A61K45/06
- A61K9/0024
- A61K9/5153
- A61P25/00
- A61P25/18
- A61P25/20
- A61P25/22
- A61P25/24
- A61P25/28
- A61P43/00
- A61K47/34
- A61K9/1647
- IPC, 14
- A61P25 00
- A61P25 28
- A61K9 51
- A61K9 00
- A61K45 06
- A61K31 519
- A61K31 5383
- A61K31 4985
- A61K31 437
- A61P43 00
- A61P25 24
- A61P25 18
- A61P25 22
- A61P25 20